MDA Space stock falls on Globalstar acquisition concerns, RBC says

Shares fell ~6% (down ~13% over the past week) after reports of a potential Globalstar acquisition raised concerns around MDA’s ~$1.1bn Globalstar direct-to-device contract. RBC Capital reiterated an Outperform and C$50.00 price target, calling the pullback a buying opportunity; MDA has completed >50% of the Globalstar work, reported backlog < ~$500m as of Q4 2025 and flagged ~ $500m at risk through 2026-27. The company raised approximately $300m in a US IPO (plus ~$41m overallotment, ~$341m gross proceeds), won a C$32m defence contract, confirmed Canadarm3 remains unaffected, and says its pipeline grew from ~$20bn to ~$40bn entering 2026.

Analysis

The market reaction is being driven less by fundamentals than by optionality and execution risk — M&A noise creates a binary event that compresses near-term liquidity and raises perceived contract tail-risk. That amplifies volatility disproportionally to the actual probability of contract loss because counterparties and lenders re-price exposure faster than procurement/regulatory processes move.

Second-order winners from any forced reshuffle will be vertically integrated satellite builders and large defense primes that can absorb work without retooling margins (they can bid below specialist suppliers for near-term continuity); conversely, niche subsystem suppliers face idiosyncratic revenue cliff risk and should see compressed forward orders and higher working-capital draw. Launch and integration schedules are the operational choke points — a buyer attempting to re-source mid-build will face calendar and certification friction that typically favors incumbent suppliers.

Tail risks and catalysts to watch: a confirmed strategic buyer or financing filing will move price within days, while contract renegotiation, formal notices, or litigation play out over months and materially affect revenue recognition and EBITDA conversion. Macro risks (FX, export controls, launch manifest slips) add multi-quarter execution noise; remediation or refinancing actions by the company would be multi-month catalysts that could restore optionality value.

Consensus is discounting much of the company’s optionality and underweighting the probability that mid-build supplier economics and legal remedies protect a meaningful portion of value. That creates asymmetric trade setups where limited, time-boxed downside protection buys meaningful upside if execution holds or markets re-rate on clearer information flows.

Key Decisions for Investors

• Directional long (MDA.TO): Buy shares sized to 1–2% NAV or buy 12-month calls (LEAPS) for asymmetric upside; set tactical stop at -25% and target +40% within 9–12 months. Rationale: event-driven overshoot likely to mean-revert as filing/clarity arrives; downside limited by incumbency frictions for re-sourcing.
• Pair trade (relative value): Long MDA.TO / Short GSAT equal notional for 3–9 months. Risk/reward: target 25–35% relative return if rumor fades or MDA outperforms on contract clarity; cap loss to 20% by unwinding if both names run >15% in same direction.
• Hedge/collar if long: Buy 6-month puts (cost ~cash layer) or sell covered calls to fund protection—sell calls at 20–30% OTM to reduce cost. Objective: protect against headline-driven gap downs while retaining upside to any affirmative contract disclosures.
• Tactical long suppliers/defense primes (NOC, LHX): Allocate ~1% NAV across 12-month horizon. Rationale: they are likely beneficiaries if work is re-sourced or if primes win integration mandates; expect durable margin capture and shorter path to cashflow.